Blair William & Co. IL Boosts Holdings in Cellebrite DI Ltd. (NASDAQ:CLBT)

Blair William & Co. IL raised its stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT) by 15.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 143,476 shares of the company’s stock after buying an additional 19,433 shares during the quarter. Blair William & Co. IL owned about 0.07% of Cellebrite DI worth $3,161,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of CLBT. JPMorgan Chase & Co. grew its stake in Cellebrite DI by 21.3% during the third quarter. JPMorgan Chase & Co. now owns 427,655 shares of the company’s stock valued at $7,202,000 after acquiring an additional 75,092 shares in the last quarter. Two Sigma Advisers LP boosted its holdings in shares of Cellebrite DI by 9.8% during the 3rd quarter. Two Sigma Advisers LP now owns 1,341,100 shares of the company’s stock valued at $22,584,000 after purchasing an additional 120,000 shares during the last quarter. Harbor Capital Advisors Inc. grew its position in shares of Cellebrite DI by 65.4% during the fourth quarter. Harbor Capital Advisors Inc. now owns 157,671 shares of the company’s stock valued at $3,473,000 after purchasing an additional 62,320 shares in the last quarter. State Street Corp lifted its position in shares of Cellebrite DI by 7.3% in the third quarter. State Street Corp now owns 443,700 shares of the company’s stock worth $7,472,000 after buying an additional 30,052 shares in the last quarter. Finally, New York State Common Retirement Fund lifted its position in shares of Cellebrite DI by 2.6% in the fourth quarter. New York State Common Retirement Fund now owns 189,599 shares of the company’s stock worth $4,177,000 after buying an additional 4,838 shares in the last quarter. Institutional investors own 45.88% of the company’s stock.

Cellebrite DI Stock Performance

Shares of Cellebrite DI stock opened at $19.43 on Tuesday. The company has a market capitalization of $4.65 billion, a PE ratio of -13.98, a P/E/G ratio of 4.27 and a beta of 1.52. The company has a 50-day simple moving average of $20.78 and a two-hundred day simple moving average of $19.93. Cellebrite DI Ltd. has a one year low of $10.25 and a one year high of $26.30.

Cellebrite DI (NASDAQ:CLBT) last posted its quarterly earnings data on Thursday, February 13th. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.10 by ($0.03). Cellebrite DI had a positive return on equity of 58.70% and a negative net margin of 70.54%. On average, equities analysts predict that Cellebrite DI Ltd. will post 0.3 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have recently commented on CLBT. Lake Street Capital increased their target price on Cellebrite DI from $17.00 to $26.00 and gave the company a “buy” rating in a research report on Friday, February 14th. Needham & Company LLC reissued a “buy” rating and issued a $28.00 price objective on shares of Cellebrite DI in a research note on Thursday, March 27th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Cellebrite DI from $24.00 to $28.00 and gave the stock an “overweight” rating in a report on Tuesday, February 11th. Seven equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $23.43.

Cellebrite DI Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.